Brachytherapy source, non-stranded, palladium-103, per source
Medicare pricing data for 21 providers across 4 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Brachytherapy source, non-stranded, palladium-103, per source (HCPCS code C2641) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $76.79, but hospitals typically charge $105.57 — a 1.4x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $76.79, your out-of-pocket cost would be approximately $15.36. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.4x more than what Medicare allows for this procedure. Medicare actually pays $61.18 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Delaware | $80 | $109 | 2 | 4,073 | +3.8% |
| Arizona | $80 | $224 | 1 | 1,408 | +3.8% |
| Florida | $78 | $84 | 5 | 1,164 | +1.5% |
| California | $75 | $90 | 10 | 10,216 | -2.2% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber